Sanofi US

Sanofi US

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

Sanofi US has headquarters in Bridgewater, New Jersey.  Our affiliate companies in the United States include Genzyme (rare diseases), Sanofi Pasteur (vaccines), Merial (animal health) and Chattem (consumer healthcare).

At Sanofi, patients and their needs are at the heart of what we do.

Videos From This Campaign

Content from this campaign

International Students Ace Lesson in CSR
International Students Ace a Lesson in Corporate Social Responsibility About 120 high school students visited Sanofi US’ headquarters in Bridgewater, NJ to learn about the implementation of Corporate Social Responsibility (CSR) at a large company. Against the backdrop of the Sanofi US headquarters Summer Olympics celebration, the site recently welcomed more than...
Sep 26, 2012 12:00 PM ET
Sanofi US Diabetes’ Use of Social Media for the Diabetes Community
Fast Company As part of Sanofi US Diabetes’ commitment to people living with diabetes, we created social media resources to connect, provide accurate information, education, encourage dialogue, and help empower people living with diabetes to make...
Aug 28, 2012 1:00 PM ET
Passionate Leadership Drives Sanofi US Supplier Diversity Program
PharmaVoice Sanofi US’ Supplier Diversity program took center stage in an article featuring the strong leadership approach of Kathleen Castore, Head of Supplier Diversity and Sustainability within NA Procurement.  Sanofi US is a company that treasures diversity to foster innovation. Based on that policy,...
Aug 27, 2012 4:00 PM ET
Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
Sanofi has entered into a partnership with Brigham and Women's Hospital (BWH) to focus on immunology of type 1 diabetes. Researchers from both organziations, who share knowledge and expertise in this area, will conduct studies that will create an immunomodulatory approach to treat type 1 diabetes. Both organziations are excited with this partnership and believe that with the resources from...
Jul 27, 2012 4:00 PM ET
Sanofi US Launches Collaborative Activate Innovation Campaign
(3BL Media) Bridgewater, NJ – July 24, 2012 – Sanofi US launched the Collaborate Activate Innovation Challenge, which will award a total of $500,000 to teams of patient advocacy groups and/or medical professional associations who deliver novel approaches to better engage patients in their own health. Based on the concept that advocates working together can make a bigger...
Jul 24, 2012 4:00 PM ET

Pages